You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

12 January 2022

Injectable PrEP approved for use in the United States

Urgent action is now needed so that people most at risk of HIV across the world can benefit

06 January 2022

Act now to tackle HIV drug resistance, WHO urges

The World Health Organization is asking countries to stop using certain types of antiretrovirals to address rising levels of drug-resistant HIV

09 December 2021

Moving from two-test to three-test HIV diagnoses

World Health Organization releases new toolkit to ensure HIV testing remains accurate as HIV prevalence falls

09 September 2021

The verdict on digitally-supported HIV self-testing

Evidence review suggests digitally-supported HIV self-testing increases testing and engages first-time testers, paving the way for greater use

19 August 2021

Is it time to shift the focus of HIV care?

Experts are calling for healthcare for people with HIV to move beyond viral suppression to address long-term health and well-being

24 February 2021

PrEP programmes are ‘missing opportunities’ to test people for sexually transmitted infections

Global evidence review finds wide variation on STI testing, despite people on PrEP being at greater risk of sexually transmitted infections.

03 February 2021

Pre-treatment drug resistant HIV high among key populations

More than 10% of men who have sex with men, sex workers and prisoners with HIV have drug resistance when beginning treatment

22 January 2021

Brazil provides more evidence on link between dolutegravir and birth defects

Review initially finds dolutegravir has no links to birth defects then revises its findings to report a ‘slightly higher’ – but minimal – incidence after two cases emerge

05 January 2021

Make ‘U=U’ discussions a standard part of HIV care, researchers urge

Global survey finds a high proportion of people living with HIV know that ‘Undetectable = Untransmittable’ – and are more likely to be healthy compared to those who are unaware.

09 December 2020

Voucher scheme to encourage young South African women to take PrEP has modest impact

Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.